Mayorga_1999_Eur.J.Pharmacol_364_7

Reference

Title : Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats - Mayorga_1999_Eur.J.Pharmacol_364_7
Author(s) : Mayorga AJ , Cousins MS , Trevitt JT , Conlan A , Gianutsos G , Salamone JD
Ref : European Journal of Pharmacology , 364 :7 , 1999
Abstract :

Four muscarinic receptor antagonists with varying selectivities for the four pharmacologically-defined muscarinic receptor subtypes (M1-M4) were administered into the lateral ventricle to determine their relative potency in reducing tremulous jaw movements induced by i.p. injection of the muscarinic receptor agonist pilocarpine (4.0 mg/kg). All four muscarinic receptor antagonists reduced tremulous jaw movements in a dose-dependent manner, with the following rank order of potency: scopolamine > methoctramine > or = telenzepine > pirenzepine. This pattern is inconsistent with the rank order of affinity of these agents at the muscarinic M1 receptor, and is consistent with their rank order of affinity at muscarinic M2 or M4 receptors. Because tremulous jaw movements are related to striatal function, and the muscarinic M4 receptor is more predominant than the muscarinic M2 receptor as a post-synaptic receptor in striatum, the present results suggest that pilocarpine induces jaw movements due to muscarinic M4 receptor stimulation. In view of the hypothesized relation between parkinsonism and cholinomimetic-induced jaw movements, these data suggest that a centrally-acting muscarinic M4 receptor antagonist could be useful as an antiparkinsonian agent.

PubMedSearch : Mayorga_1999_Eur.J.Pharmacol_364_7
PubMedID: 9920179

Related information

Citations formats

Mayorga AJ, Cousins MS, Trevitt JT, Conlan A, Gianutsos G, Salamone JD (1999)
Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats
European Journal of Pharmacology 364 :7

Mayorga AJ, Cousins MS, Trevitt JT, Conlan A, Gianutsos G, Salamone JD (1999)
European Journal of Pharmacology 364 :7